Target Price | €6.00 |
Price | €1.62 |
Potential |
270.83%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a MediGene AG price target 2025.
The average MediGene AG target price is €6.00.
This is
270.83%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend MediGene AG to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MediGene AG stock has an average upside potential 2025 of
270.83%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million € | 6.03 | 11.00 |
80.70% | 82.42% | |
EBITDA Margin | -249.25% | -111.82% |
711.88% | 55.14% | |
Net Margin | -305.56% | -129.98% |
1,805.30% | 57.46% |
1 Analyst has issued a sales forecast MediGene AG 2024 . The average MediGene AG sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast MediGene AG 2024 . The average MediGene AG EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | -1.25 | -0.97 |
267.65% | 22.40% | |
P/E | negative | |
EV/Sales | 0.16 |
Based on analysts' sales estimates for 2024, the MediGene AG stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.